Sort
25,944 grants matching “neurodegeneration”
Brain pathologies, reserve and cognition in aging and dementia
$1,568,333Sarah E Tomaszewski-Farias · University Of California At Davis · R01 · FY2022 · AG
MECHANISMS UNDERLYING MICROGLIA DYSFUNCTION DURING NEURODEGENERATION
$1,568,017Elizabeta Gjoneska · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Connectomic imaging in familial and sporadic frontotemporal degeneration
$1,567,733Murray Grossman · University Of Pennsylvania · U01 · FY2019 · AG
Connectomic imaging in familial and sporadic frontotemporal degeneration
$1,567,733Murray Grossman · University Of Pennsylvania · U01 · FY2018 · AG
ESTROGEN AND THE AGING BRAIN
$1,567,542Mount Sinai School Of Medicine Of Nyu · P01 · FY2002 · AG
Protein Phosphorylation And Regulation Of Cytoskeleton In Neuronal Systems
$1,565,557Harish C Pant · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-alpha1 in Neural and Cognitive Functions
$1,563,833Y. Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
La Jolla-Parkinson's Disease Center Grant
$1,563,791Stuart A Lipton · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2011 · ES
Brain fluid clearance and misfolded protein dynamics following traumatic brain injury
$1,563,781Tracy A. Butler · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AG
MAEVE: Microbiota mediated flavonoid metabolites for cognitive health
$1,563,756Arpana Church · University Of California Los Angeles · R01 · FY2024 · AG
Mechanisms of PhIP-induced dopaminergic neurotoxicity
$1,563,395Jason R Cannon · Purdue University · R01 · FY2023 · ES
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
$1,562,430Sara Hagg · Karolinska Institute · RF1 · FY2021 · AG
Major Cyclotron Upgrades and Refurbishment
$1,562,230Douglas J Ballon · Weill Medical Coll Of Cornell Univ · S10 · FY2021 · OD
Functional Genetics of Susceptibility to Prions
$1,561,788Mc Laughlin Research Institute · P01 · FY2002 · NS
BIOLOGY OF SPATIOTEMPORAL NITRIC OXIDE GRADIENTS
$1,561,468University Of Wyoming · P20 · FY2000 · RR
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers
$1,561,246Allan I Levey · Emory University · U01 · FY2022 · AG
G-quadruplex DNA in senescence of the neurovascular unit
$1,560,000Andrey Tsvetkov · University Of Texas Hlth Sci Ctr Houston · RF1 · FY2020 · AG
CNS &Peripheral Viral Reservoirs/SIV Model of HIV HAART
$1,558,186Johns Hopkins University · P01 · FY2004 · MH
Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models
$1,557,889Joshua M Shulman · Baylor College Of Medicine · U01 · FY2025 · AG
CNS & Peripheral Viral Reservoirs/SIV Model of HIV HAART
$1,557,728Janice Ellen Clements · Johns Hopkins University · P01 · FY2006 · MH
Blood Pressure and ADRD in African Americans: the Jackson Heart Study
$1,556,922Priya Palta · Columbia University Health Sciences · R01 · FY2022 · AG
Interdisciplinary Research to Understand the Interplay of Diabetes, Cerebrovascular disease and Alzheimers disease
$1,555,003Jose A Luchsinger · Columbia University Health Sciences · RF1 · FY2019 · AG
Blood Pressure and ADRD in African Americans: the Jackson Heart Study
$1,554,910Priya Palta · Columbia University Health Sciences · R01 · FY2021 · AG
Advanced therapeutic for Parkinson's Disease
$1,554,563Milton H. Werner · Inhibikase Therapeutics · R44 · FY2018 · NS
Advanced therapeutic for Parkinson's Disease
$1,554,108Milton H. Werner · Inhibikase Therapeutics · R44 · FY2019 · NS